search button
Open Access

Tumor‑suppressive miR‑299‑3p inhibits gastric cancer cell invasion by targeting heparanase

  • Authors:
    • Xiangjun Zhou
    • Mengmou Hu
    • Zhenghui Ge

  • View Affiliations

  • Published online on: June 27, 2019     https://doi.org/10.3892/mmr.2019.10436
  • Pages: 2151-2158

  • Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastric cancer (GC) remains a leading cause of cancer‑associated mortality globally. Emerging evidence suggests that microRNAs (miRs) function as oncogenes or tumor suppressors, contributing to various aspects of cancer progression, including invasion and metastasis. In the present study, the specific role of miR‑299‑3p in the invasion of GC cells was investigated. The expression level of miR‑299‑3p was measured using reverse transcription‑quantitative PCR and in situ hybridization in human GC tissues. Effects of miR‑299‑3p on GC cell invasion were determined by Transwell assay. Bioinformatics and luciferase reporter assays were performed to identify and verify the downstream effectors of miR‑299‑3p. miR‑299‑3p expression analysis in clinical GC samples revealed a significant downregulation of miR‑299‑3p compared with non‑tumor tissues. Inhibition of miR‑299‑3p promoted the invasive abilities of GC cells, whereas its overexpression significantly suppressed cell invasion. Bioinformatics and luciferase reporter assays identified heparanase (HPSE) as a direct target of miR‑299‑3p, the ectopic expression of which reversed the impairment in cell invasion induced by miR‑299‑3p upregulation. Furthermore, HPSE expression was negatively associated with miR‑299‑3p levels in human GC tissues. Overall, the present study indicated that miR‑299‑3p functions as a tumor suppressor by directly targeting HPSE, highlighting its potential as a target for the treatment of GC.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 20 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 7.6
  • CiteScore Rank: Q1: #82/347 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 0.647
  • SCImago Journal Rank (SJR): 0.781
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou X, Hu M and Ge Z: Tumor‑suppressive miR‑299‑3p inhibits gastric cancer cell invasion by targeting heparanase. Mol Med Rep 20: 2151-2158, 2019.
APA
Zhou, X., Hu, M., & Ge, Z. (2019). Tumor‑suppressive miR‑299‑3p inhibits gastric cancer cell invasion by targeting heparanase. Molecular Medicine Reports, 20, 2151-2158. https://doi.org/10.3892/mmr.2019.10436
MLA
Zhou, X., Hu, M., Ge, Z."Tumor‑suppressive miR‑299‑3p inhibits gastric cancer cell invasion by targeting heparanase". Molecular Medicine Reports 20.3 (2019): 2151-2158.
Chicago
Zhou, X., Hu, M., Ge, Z."Tumor‑suppressive miR‑299‑3p inhibits gastric cancer cell invasion by targeting heparanase". Molecular Medicine Reports 20, no. 3 (2019): 2151-2158. https://doi.org/10.3892/mmr.2019.10436